The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Efficacy of gabapentin in the management of chemotherapy‐induced peripheral neuropathy: A phase 3 randomized, double‐blind, placebo‐controlled, crossover trial (N00C3)
Abstract
BACKGROUND.: The antiepileptic agent, gabapentin, has been demonstrated to relieve symptoms of peripheral neuropathy due to various etiologies. On the basis of these data, a multicenter, double‐blind, placebo‐controlled, crossover, randomized trial was conducted to evaluate the effect of gabapentin on symptoms of chemotherapy‐induced peripheral neuropathy (CIPN). METHODS.: Patients with symptomatic CIPN who complained of ‘average’ daily pain scores of either 1) ≥4 on a 0–10 numerical rating scale (NRS); or 2) ≥1 on the 0–3 Eastern Cooperative Oncology Group neuropathy scale (ENS) were eligible (higher numbers indicate greater severity of symptoms in both scales). Patients were randomized to receive gabapentin (target dose, 2700 mg) or placebo for 6 weeks. Crossover occurred after a 2‐week washout period. CIPN‐related symptoms were evaluated weekly by questionnaires. Statistical methods followed established methods for crossover designs, including Student t tests to compare average intrapatient differences between treatments and linear models to adjust for potential concomitant covariates. RESULTS.: There were 115 patients who were randomly assigned to the treatment or control arm. Both groups were well matched by symptoms at study entry. Changes in symptom severity were statistically similar between the 2 groups during the study. Adverse events were mild and similar in both groups. CONCLUSIONS.: This trial failed to demonstrate any benefit to using gabapentin to treat symptoms caused by CIPN. Cancer 2007. © 2007 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toxicity and response criteria of the Eastern Cooperative Oncology Group
Oken, M. M., Creech, R. H., Tormey, D. C., Horton, J., Davis, T. E., McFadden, E. T., & Carbone, P. P. (1982) · AMERICAN JOURNAL OF CLINICAL ONCOLOGY · doi:10.1097/00000421-198212000-00014 · Cited by 11,647
Reporting results of cancer treatment
Miller, A. B., Hoogstraten, B., Staquet, M., & Winkler, A. (1981) · Cancer · doi:10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6 · Cited by 7,793
Farrar, J. T., Young, J. P., LaMoreaux, L., Werth, J. L., & Poole, M. R. (2001) · Pain · doi:10.1016/s0304-3959(01)00349-9 · Cited by 5,808
Pain assessment: global use of the Brief Pain Inventory.
Cs, C., & Km, R. (1994) · PubMed · Cited by 5,421
The short-form McGill pain questionnaire
Melzack, R. (1987) · Pain · doi:10.1016/0304-3959(87)91074-8 · Cited by 4,368
Pocock, S. J., & Simon, R. (1975) · Biometrics · doi:10.2307/2529712 · Cited by 2,350
Douillard, J.-Y., Rosell, R., De Lena, M., Carpagnano, F., Ramlau, R., Gonzáles-Larriba, J. L., Grodzki, T., Pereira, J. R., Le Groumellec, A., Lorusso, V., et al. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70804-x · Cited by 1,573
Rowbotham, M. (1998) · JAMA · doi:10.1001/jama.280.21.1837 · Cited by 1,433
Morphine, Gabapentin, or Their Combination for Neuropathic Pain
Gilron, I., Bailey, J. M., Tu, D., Holden, R. R., Weaver, D. F., & Houlden, R. L. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042580 · Cited by 1,091
Development of a symptom distress scale
MCCORKLE, R., & YOUNG, K. (1978) · Cancer Nursing · doi:10.1097/00002820-197810000-00003 · Cited by 811
Cross-Over Trials in Clinical Research
(1994) · Technometrics · doi:10.1080/00401706.1994.10485798 · Cited by 763
Rosenstock, J., Tuchman, M., LaMoreaux, L., & Sharma, U. (2004) · Pain · doi:10.1016/j.pain.2004.05.001 · Cited by 725
Luo, Z. D., Chaplan, S. R., Higuera, E. S., Sorkin, L. S., Stauderman, K. A., Williams, M. E., & Yaksh, T. L. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-06-01868.2001 · Cited by 616
Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial
Serpell, M. G. (2002) · Pain · doi:10.1016/s0304-3959(02)00255-5 · Cited by 433
Luo, Z. D., Calcutt, N. A., Higuera, E. S., Valder, C. R., Song, Y.-H., Svensson, C. I., & Myers, R. R. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.041574 · Cited by 381
Dougherty, P. M., Cata, J. P., Cordella, J. V., Burton, A., & Weng, H.-R. (2004) · Pain · doi:10.1016/j.pain.2004.01.021 · Cited by 369
Field, M. J., Oles, R. J., Lewis, A. S., McCleary, S., Hughes, J., & Singh, L. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701320 · Cited by 326
Caraceni, A., Zecca, E., Bonezzi, C., Arcuri, E., Tur, R. Y., Maltoni, M., Visentin, M., Gorni, G., Martini, C., Tirelli, W., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.141 · Cited by 319
BONE, M., CRITCHLEY, P., & BUGGY, D. (2002) · Regional Anesthesia and Pain Medicine · doi:10.1053/rapm.2002.35169 · Cited by 274
Hammack, J. E., Michalak, J. C., Loprinzi, C. L., Sloan, J. A., Novotny, P. J., Soori, G. S., Tirona, M. T., Rowland, K. M., Stella, P. J., & Johnson, J. A. (2002) · Pain · doi:10.1016/s0304-3959(02)00047-7 · Cited by 231
Self-citationGabapentin affects glutamatergic excitatory neurotransmission in the rat dorsal horn
Shimoyama, M., Shimoyama, N., & Hori, Y. (2000) · Pain · doi:10.1016/s0304-3959(99)00283-3 · Cited by 189
Gabapentin as an Adjuvant to Opioid Analgesia for Neuropathic Cancer Pain
Caraceni, A., Zecca, E., Martini, C., & De Conno, F. (1999) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(99)00033-0 · Cited by 179
Cross-Over Trials in Clinical Research
Ziegel, E. R., & Senn, S. (1994) · Technometrics · doi:10.2307/1270263 · Cited by 177
Inhibition of Paclitaxel-Induced A-Fiber Hypersensitization by Gabapentin
Matsumoto, M., Inoue, M., Hald, A., Xie, W., & Ueda, H. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.103614 · Cited by 142
Quality of Life in Hospice Patients
Bretscher, M. E., Rummans, T. A., Sloan, J. A., Kaur, J. S., Bartlett, A., Borkenhagen, L. S., & Loprinzi, C. L. (1999) · Psychosomatics · doi:10.1016/s0033-3182(99)71224-7 · Cited by 135
Self-citationLeach, J. P., Girvan, J., Paul, A., & Brodie, M. J. (1997) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.4.372 · Cited by 129
Fairclough, D. L., Peterson, H. F., Cella, D. F., & Bonomi, P. (1998) · Statistics in Medicine · Cited by 122
Gabapentin in the prophylaxis of migraine: a double-blind randomized placebo-controlled study.
Trapani, G. D., Mei, D., Marra, C., Mazza, S., & Capuano, A. (2000) · PubMed · Cited by 103
Bačkonja, M.-M. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb00934.x · Cited by 79
Ross, J. R., Goller, K., Hardy, J. R., Riley, J. L., Broadley, K. E., A’Hern, R., & Williams, J. E. (2005) · Journal of Palliative Medicine · doi:10.1089/jpm.2005.8.1118 · Cited by 74
Weekly cisplatin ± glutathione in relapsed ovarian carcinoma
Colombo, N., BINI, S., Miceli, D. D., Bogliun, G., Marzorati, L., Cavaletti, G., Parmigiani, F., Venturino, P., Tedeschi, M., Frattola, L., et al. (1995) · International Journal of Gynecological Cancer · doi:10.1046/j.1525-1438.1995.05020081.x · Cited by 44
Cited by
Seretny, M., Currie, G. L., Sena, E. S., Ramnarine, S., Grant, R., MacLeod, M. R., Colvin, L. A., & Fallon, M. (2014) · Pain · doi:10.1016/j.pain.2014.09.020 · Cited by 1,555
Dworkin, R. H., O'Connor, A. B., Audette, J., Baron, R., Gourlay, G. K., Haanpää, M. L., Kent, J. L., Krane, E. J., LeBel, A. A., Levy, R. M., et al. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0649 · Cited by 1,325
Hershman, D. L., Lacchetti, C., Dworkin, R. H., Lavoie Smith, E. M., Bleeker, J., Cavaletti, G., Chauhan, C., Gavin, P., Lavino, A., Lustberg, M. B., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.0914 · Cited by 1,209
Self-citationLoprinzi, C. L., Lacchetti, C., Bleeker, J., Cavaletti, G., Chauhan, C., Hertz, D. L., Kelley, M. R., Lavino, A., Lustberg, M. B., Paice, J. A., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.01399 · Cited by 1,113
Self-citationThe evidence for pharmacological treatment of neuropathic pain
Finnerup, N. B., Sindrup, S. H., & Jensen, T. S. (2010) · Pain · doi:10.1016/j.pain.2010.06.019 · Cited by 1,045
Metadata
- Authors
- Rao, R. D., Michalak, J. C., Sloan, J. A., Loprinzi, C. L., Soori, G. S., Nikcevich, D. A., Warner, D. O., Novotny, P., Kutteh, L. A., Wong, G. Y., & and the North Central Cancer Treatment Group
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2007-10-18
- Volume
- 110
- Issue
- 9
- Pages
- 2110-2118
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2090907917
- Cited by
- 360
- References
- 31
- FWCI
- 5.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.